May 11,2016

LabStyle Innovations Reports Q1 2016 Results

LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Diabetes Management Solution, today reported financial and operational results for the quarter ended March 31, 2016 and provided an outlook for the coming quarters. Some of the highlights are: Quarterly gross loss narrowed 61% compared to Q4 2015, Net loss narrowed by 29% compared to Q4 2015 and Launched Dario Blood Glucose Monitoring System in the United States late in the first quarter. Sequential quarterly revenues from distribution partners and customers of products and software services increased 84% from $308,000 in Q4 2015 to $568,000 in Q1 2016.

View Analyst & Ambassador Comments
Go to original news
May 17,2016

ASCENSIA DIABETES CARE RECEIVES CE MARK FOR THE STATE-OF-THE-ART CONTOUR™ NEXT ONE AND CONTOUR™ PLUS ONE BLOOD GLUCOSE MONITORING SYSTEMS

Today, Ascensia Diabetes Care announced that it has received CE Mark (Conformité Européenne) for the new CONTOUR™ NEXT ONE and CONTOUR™ PLUS ONE blood glucose monitoring systems, the next exciting development in the evolution of self-monitoring of blood glucose for people with diabetes.

REGULATORY CE MARK

#bgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
May 20,2016

Interim information Jan-Mar 2016 has been published

Brighter has published its interim information january - march 2016. It is available only in Swedish.

View Analyst & Ambassador Comments
Go to original news
May 23,2016

Insulet Launches New Omnipod® Podder™ Community Platform

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced the launch of a new online user community platform. This new platform will increase patient engagement and awareness of Omnipod by empowering Omnipod customers to share their experiences and insights and provide support to the large and growing Podder™ community.

PRODUCT

#insulin pump

#mobile app

View Analyst & Ambassador Comments
Go to original news
May 27,2016

LabStyle Innovations to Present at Upcoming Investor Conferences

LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Diabetes Management Tool, today announced that the Company's Chief Financial Officer, Zvi Ben-David will present at the Marcum MicroCap Conference being held June 1-2 in New York, NY and the LD Micro Invitational, being held June 7-9 in Los Angeles, CA.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jun 11,2016

WellDoc® Announces Results of a Collaborative Study Showing Sustained Patient Engagement through the Use of BlueStar® and Lay Coaching

Digital health technology leader WellDoc® today announced results from a real-world study designed to evaluate the feasibility and reach of using a lay coach in conjunction with BlueStar® mobile prescription therapy to provide ongoing self-management support for people living with type 2 diabetes in a primary care setting. The data were featured via a poster presented today at the American Diabetes Association’s (ADA) 76th Scientific Sessions, taking place now at the Ernest N. Morial Convention Center in New Orleans, Louisiana.

CLINICAL STUDY

#coaching

View Analyst & Ambassador Comments
Go to original news
Jun 10,2016

Glooko announces new ‘Glooko Advise’ decision support product line at the 2016 American Diabetes Association Conference

Glooko Inc., the leading unified platform for diabetes management, today announced its new ‘Glooko Advise’ product line, including ‘Glooko Personal Advisor’ and ‘Glooko Clinical Advisor,’ which enables both people with diabetes (PWDs) and clinicians with practical diabetes decision support. Glooko Personal Advisor aims to help PWDs better understand their retrospective diabetes data and improve daily decisions by using proprietary pattern recognition algorithms to recognize trends and deliver targeted educational content based on those trends.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Jun 13,2016

Medtronic touts ‘closed-loop’ insulin management system

Nutrino and Medtronic inked a deal to link Nutrino’s nutrition app with Medtronic’s MiniMed Connect and CareLink, providing patients with a”FoodPrint”: Meal plans and food suggestions customized for carbohydrate intake and glucose levels. The Nutrino app also connects with wellness devices and activity trackers such as Apple’s HealthKit, Runkeeper, Moves, Jawbone, Withings and Fitbit.

COLLABORATION PARTNERSHIP

#connected device

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 15,2016

Medtronic inks partnership deal with self-management program dev Canary Health

Medtronic (NYSE:MDT) is partnering with digital health self-management program developer Canary Health to resell and distribute its full suite of chronic disease self-management programs, including its Diabetes Prevention Program. Through the partnership, the 2 companies will also develop additional solutions that operate around Medtronic’s devices, services and infrastructure as well as Canary Health’s platform of behavior change programs.

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Jun 17,2016

Solera Health raises another $4M for its diabetes prevention programs marketplace

Phoenix, Arizona-based Solera Health added another $4 million in funding from investors to help connect providers, payers and patients with diabetes prevention programs available in their area. The company announced $3 million in funding last November. Return backers BlueCross BlueShield Venture Partners and Sandbox Ventures participated in the new injection of funds as did new investor, social impact fund, SJF Ventures.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES